Replies to post #572316 on NorthWest Biotherapeutics Inc (NWBO)

[biosectinvestor]

Yes, has always been a sign that the UK views DCVax-L in a favorable light. It's not relevant to the ILAP designation but DCVax-L I would say clearly falls under the appropriate categories to fit into that newer and unrelated program.